Get started
Author

Wolfgang Fleischhacker

Observed names: Fleischhacker, Wolfgang, WOLFGANG FLEISCHHACKER, Wolfgang W Fleischhacker, Wolfgang W. Fleischhacker, Wolfgang W. Wolfgang Fleischhacker
Observed institutions: Innsbruck Medical University, King's College London, Universität Innsbruck, NYU Langone Health, Krankenhaus Brixen, University Hospital Innsbruck, Weill Cornell Medicine, Janssen Research & Development (United States)
OpenAlex ID: A5112081052
Cognitive Effects of Antipsychotic Drugs in First-Episode Schizophrenia and Schizophreniform Disorder: A Randomized, Open-Label Clinical Trial (EUFEST)
2009 · Michael Davidson, Silvana Galderisi, et al. · American Journal of Psychiatry · 314
Quality of Life in Breast Cancer Patients—Not Enough Attention for Long-Term Survivors?
2001 · Bernhard Holzner, Georg Kemmler, et al. · Psychosomatics · 228
Multisite prediction of 4-week and 52-week treatment outcomes in patients with first-episode psychosis: a machine learning approach
2016 · Nikolaos Koutsouleris, René S Kahn, et al. · The Lancet Psychiatry · 219
Amisulpride and olanzapine followed by open-label treatment with clozapine in first-episode schizophrenia and schizophreniform disorder (OPTiMiSE): a three-phase switching study
2018 · René S Kahn, Inge Winter van Rossum, et al. · The Lancet Psychiatry · 197
Stratified medicine for mental disorders
2013 · Gunter Schumann, Elisabeth B. Binder, et al. · European Neuropsychopharmacology · 185
PDF
Efficacy and Safety of Paliperidone Palmitate 3-Month Formulation for Patients with Schizophrenia: A Randomized, Multicenter, Double-Blind, Noninferiority Study
2016 · Adam J. Savitz, Haiyan Xu, et al. · The International Journal of Neuropsychopharmacology · 163
PDF
Akathisia: An Updated Review Focusing on Second-Generation Antipsychotics
2009 · John M. Kane, Wolfgang W. Fleischhacker, et al. · The Journal of Clinical Psychiatry · 153
Bitopertin in Negative Symptoms of Schizophrenia—Results From the Phase III FlashLyte and DayLyte Studies
2016 · Dragana Bugarski-Kirola, Thomas Blaettler, et al. · Biological Psychiatry · 145
Advantages and disadvantages of combination treatment with antipsychotics
2009 · Guy Goodwin, Wolfgang Fleischhacker, et al. · European Neuropsychopharmacology · 145
Compliance in Schizophrenia: Psychopathology, Side Effects, and Patients’ Attitudes Toward the Illness and Medication
2004 · Maria A. Rettenbacher, Alex Hofer, et al. · The Journal of Clinical Psychiatry · 124
Correlates of cognitive impairment in first episode schizophrenia: The EUFEST study
2009 · Silvana Galderisi, Michael Davidson, et al. · Schizophrenia Research · 123
The efficacy of cariprazine in negative symptoms of schizophrenia: Post hoc analyses of PANSS individual items and PANSS-derived factors
2019 · Wolfgang Fleischhacker, Silvana Galderisi, et al. · European Psychiatry · 115
PDF
Use of alternative / complementary therapy in breast cancer patients - a psychological perspective
2001 · Roland Moschèn, Georg Kemmler, et al. · Supportive Care in Cancer · 103
Antidepressant medications and other treatments of depressive disorders: a CINP Task Force report based on a review of evidence
2007 · Norman Sartorius, Thomas C. Baghai, et al. · The International Journal of Neuropsychopharmacology · 98
PDF
Stratification and prediction of remission in first-episode psychosis patients: the OPTiMiSE cohort study
2019 · Emanuela Martinuzzi, Susana Barbosa, et al. · Translational Psychiatry · 74
PDF
The effects of second-generation antipsychotics on cognitive functioning and psychosocial outcome in schizophrenia
2002 · Elisabeth M. Weiss, Robert M. Bilder, et al. · Psychopharmacology · 63
Clozapine Optimization: A Delphi Consensus Guideline From the Treatment Response and Resistance in Psychosis Working Group
2023 · Elias Wagner, Dan Siskind, et al. · Schizophrenia Bulletin · 46
PDF
CSF of neuroleptic-naive first-episode schizophrenic patients: Levels of biogenic amines, substance P, and peptides derived from chromogranin A (GE-25) and secretogranin II (secretoneurin)
1996 · Carl Miller, Rudolf Kirchmair, et al. · Biological Psychiatry · 44
Affective prosody perception in symptomatically remitted patients with schizophrenia and bipolar disorder
2014 · Christine M. Hoertnagl, Nursen Yalcin-Siedentopf, et al. · Schizophrenia Research · 20
How antipsychotics impact the different dimensions of Schizophrenia: A test of competing hypotheses
2014 · Tiago Reis Marques, Stephen Z. Levine, et al. · European Neuropsychopharmacology · 17
Treatment of psychotic and behavioral symptoms with clozapine, aripiprazole, and reboxetine in a patient with Huntington’s disease
2013 · Monika Edlinger, Klaus Seppi, et al. · International Clinical Psychopharmacology · 15
Aripiprazole treatment for patients with schizophrenia: from acute treatment to maintenance treatment
2011 · Min-Hyeon Park, Changsu Han, et al. · Expert Review of Neurotherapeutics · 14
Executive Dysfunctions Predict Self-Restricted Driving Habits in Elderly People with or without Alzheimer’s Dementia
2017 · Ilsemarie Kurzthaler, Georg Kemmler, et al. · Pharmacopsychiatry · 13
[Neurocognition and social cognition in patients with schizophrenia or mood disorders].
2010 · Alex Hofer, Falko Biedermann, et al. · PubMed · 13
Relapse in Schizophrenia: A Systematic Review of Criteria for Clinical Studies and International Consensus Guidelines to Improve Them
2025 · Oliver D. Howes, Bernard R. Bukala, et al. · American Journal of Psychiatry · 12
Works count: 70
Citation count: 2,697
H-index: 19
I10-index: 26
Year
Topic
Type